Reilly Financial Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Reilly Financial Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-512	Closed	-$28K	–	1107
2017 Q4	$28K	Sell	512 -25	-5%	-$1.37K	﹤0.01%	429
2017 Q3	$31K	Hold	537	–	–	﹤0.01%	391
2017 Q2	$32K	Sell	537 -27	-5%	-$1.54K	﹤0.01%	394
2017 Q1	$31K	Buy	+564	New	+$27.8K	0.01%	388

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Reilly Financial Advisors's BIVV Position: Q1 2018 in Review

Reilly Financial Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 512 shares — an estimated $28K sold.

Reilly Financial Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $32K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Reilly Financial Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Reilly Financial Advisors sold 512 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $28K.
Reilly Financial Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Reilly Financial Advisors's Bioverativ Inc. Common Stock position peaked at $32K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Reilly Financial Advisors's 13F filing for Q1 2018, filed 30 Apr 2018.